Albion Crown Vct Plc · LSE:CRWC

Albion Crown Vct — Crown Place VCT — Shareholder Meeting (November 2022)

26 slides from Albion Crown Vct's shareholder meeting presentation, Nov 21, 2022

  1. Slide 1: Crown Place VCT PLC Results for the year to June 2022

    Crown Place VCT PLC Results for the year to 30 June 2022 AGM November 2022 Crown Place VCT PLC– AGM Nov 2022

  2. Slide 2: Agenda

    Agenda • Financial highlights • Background • Track record • Highlights in the year • Investment portfolio • Realisations • Investment strategy • ESG & responsible investing • Prospects, Q1 results and shareholder events 2 Crown Place VCT PLC– AGM Nov 2022

  3. Slide 3: Financial highlights to June 2022

    Financial highlights to June 2022 33.70p Net asset value (NAV) per share as at 30 June 2022 2.12p Increase in total shareholder value for the year ended 30 June 2022 6.1% Movement in shareholder value in the year 1.71p Tax-free dividends per share paid during the year 4.9% Tax-free dividend yield on

  4. Slide 4: Background

    Background • Continued impact of Covid-19 during the • Positive return of the portfolio, despite headwinds, financial year resulting in economic generated by software, healthcare and asset-based dislocations and supply chain problems investments • Repricing of public markets, especially in • Portfol

  5. Slide 5: Track record

    Track record Performance Data for year to 30 June 2022 1 year average 6.1% p.a. 1 year return 3 year average 6.8% p.a. 5 year average 10.0% p.a. 3 year return 10 year average 8.0% p.a. 5 year return 10 year return 0.0% 10.0% 20.0% 30.0% 40.0% 50.0% 60.0% 70.0% 80.0% 90.0% Increase in shareholder val

  6. Slide 6: Highlights in the year

    Highlights in the year 2021 2022 Notes Fundraising £8.8m £11.7m 2020/21 and 2021/22 Top-up Offers Exits £12.3m £7.2m Profit on cost of £4.5m £2.0m into 4 new companies and £5.7m into existing Investment rate £8.3m £7.7m portfolio Share buybacks £1.7m £2.2m Dividends £7.3m £7.4m £3.3m of special divi

  7. Slide 7: Key value drivers in the year

    Key value drivers in the year 2022 Notes Credit Kudos £1.9m Sold during the year MyMeds&Me £0.9m Sold during the year Phrasee £0.6m Sold during the year Other – write ups £5.3m Across 38 companies (excluding the top 3 above) Other – write downs (£2.3m) Across 18 companies Total £6.4m 7 Crown Place V

  8. Slide 8: Portfolio analysis by value

    Portfolio analysis by value Sector breakdown Portfolio of 60 companies employing over 3,800 people predominantly in the UK 8 Comparatives for 30 June 2021 are in brackets. Crown Place VCT PLC– AGM Nov 2022

  9. Slide 9: Portfolio analysis by value

    Portfolio analysis by value Stage of investment No. of employees * Renewable energy investments have no employees 9 Comparatives for 30 June 2021 are in brackets. Crown Place VCT PLC– AGM Nov 2022

  10. Slide 10: The top investments account for 20.2% of the NAV at June 2022

    The top 3 investments account for 20.2% of the NAV at 30 June 2022 Investment Cost Book value Revenue Employee date £000 £000 growth growth Network analytics platform 30 to used to uncover hidden risks 2017 1,797 10,119 >30x >400 and opportunities Reformulation of medicines Nil to 2012 974 3,908 4 t

  11. Slide 11: New investments

    New investments Uses an AI powered Provides insights and An autonomous and Provider of machine platform to guide analytics to ethical debt resolution readable structured people through every pharmaceutical platform regulatory content stage of their relocation companies about therapeutic areas. £0.7m

  12. Slide 12: New investment: PerchPeek

    New investment: PerchPeek • The global employee relocation market is worth $33.5bn, a large market due to the costs and complexity involved in A disruptor to the antiquated relocation making relocation possible market, Perchpeek uses an AI powered platform to guide people through every • Relocation

  13. Slide 13: New investment: PeakData AG

    New investment: PeakData AG • Allows pharma companies to find top-tier experts and identify emerging influencers - crucial for those with limited resources Launched in 2018, PeakData enables pharmaceutical companies for the first • This essential mapping means patients benefit from time to map the h

  14. Slide 14: New investment: Ophelos

    New investment: Ophelos • A software platform using machine learning and analytics to create a better and more effective debt collection process Ophelos’s debt resolution platform marries • By empowering debtors to manage when, where and how machine learning, advanced analytics and they repay, the p

  15. Slide 15: £5.7m follow-ons

    £5.7m follow-ons A technology enabled A provider of a connectivity The most accurate speech-to- service providing medical solution, connecting text technology in the market, nutritional therapy financial institutions with covering over 30 languages trading venues via a single API. 15 Crown Place VCT

  16. Slide 16: Realisations: Credit Kudos

    Realisations: Credit Kudos Acquired by Apple £3.0m Invested by Albion VCTs Challenger credit bureau helping lenders optimise and automate their affordability and risk assessments 5.2x Return on Cost £2.4m CRWN proceeds 2 years Period invested 16 Crown Place VCT PLC– AGM Nov 2022

  17. Slide 17: Realisations: Phrasee

    Realisations: Phrasee Acquired by Capital D and Keyhaven Capital Partners £4.0m Invested by Albion VCTs An AI-powered SaaS platform that revolutionises customer experiences 3.5x Return on Cost through Brand Language Optimization £2.2m CRWN proceeds 3.5 years Period invested 17 Crown Place VCT PLC– A

  18. Slide 18: Realisations: MyMeds&Me

    Realisations: MyMeds&Me Acquired by Drug Safety and Pharmacovigilance Services Solutions (DSS) £3.3m Invested by Albion VCTs Provides a platform for collecting data on pharmaceutical adverse events 3.4x Return on Cost £1.5m CRWN proceeds 9 years Period invested 18 Crown Place VCT PLC– AGM Nov 2022

  19. Slide 19: Investment strategy

    Investment strategy From Seed Backing Focus on • Software and tech Long-term Business-to-Business enabled services to Series B (early stage trends (B2B) • Healthcare to growth) products and services 19 Crown Place VCT PLC– AGM Nov 2022

  20. Slide 20: Growth platform - Helping our portfolio companies to scale up

    Growth platform - Helping our portfolio companies to scale up • Led by Jane Reddin, Partner • Coach founders to become leaders • Hire C level talent • Develop cohesive leadership teams • Advice on go-to-market strategies • Financial discipline and fundraising 20 Crown Place VCT PLC– AGM Nov 2022

  21. Slide 21: ESG and responsible investing

    ESG and responsible investing Our commitment • Devise an appropriate risk-return profile for our investments • Deliver value to our investors • Develop sustainable long-term strategies for our portfolio companies Our process • Integrates ESG principles at all stages of investment • Measures the sust

  22. Slide 22: ESG in investment process

    ESG in investment process 1. 2. Due 3. 4. 5. Screening diligence Monitoring Follow-ons Exits • Check company • ESG Due Diligence • Leverage portfolio • Reassess ESG risks and • Support the company activity with exclusion completed pre- company board to opportunities at each in demonstrating to list

  23. Slide 23: ESG within our business

    ESG within our business • Monitoring carbon footprint • Future VC, a paid internship and • Updated ESG approach as mentoring of participants part of our investment • Net zero carbon emissions process strategy designed • Fair HQ, working with expert consultancy to establish diverse and • Regular ESG

  24. Slide 24: Prospects

    Prospects • Ongoing macroeconomic and geopolitical uncertainties impacting technology and healthcare sector growth and valuations • Well-balanced portfolio by sector and stage of maturity • Asset-based portfolio resilience, particularly renewable energy • Focus on mission critical products and servi

  25. Slide 25: Q1 results and shareholder events

    Q1 results and shareholder events • NAV at 30 September 2022 of 33.77p • Virtual AGMs • An increase of 0.2% for the quarter • Annual shareholder seminar was held at Royal • £3.6m in 4 new investments and 4 follow-on investments College of Surgeons on 23 Nov 2022 • First dividend 0.84p per share to b

  26. Slide 26: Thank you

    Thank you This presentation is for information purposes only and is not to be regarded as an offer to buy or sell, or the solicitation to buy or sell shares in Crown Place VCT PLC. Any person considering an investment should seek advice from an authorised financial advisor. Albion Capital Group LLP

Crown Place VCT — Shareholder Meeting (November 2022) on 6ix